SECsense Logo

Pulse Biosciences, Inc. 8-K Filing Report: Key Insights as of January 9, 2025

$PLSE
Form 8-K
Filed on: 2025-01-13
Source
Pulse Biosciences, Inc. 8-K Filing Report: Key Insights as of January 9, 2025

Based on the extracted XML section of the financial report for Pulse Biosciences, Inc., here are the key pieces of information:

  1. Filing Type and Date:
  • The document is an 8-K filing, indicating it contains current event information.
  • The filing date is January 9, 2025.
  1. Company Information:
  • Name: Pulse Biosciences, Inc.
  • CIK (Central Index Key): 0001625101
  • Entity Type: Corporation
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-37744
  • EIN (Employer Identification Number): 46-5696597
  • Address: 601 Brickell Key Drive, Suite 1080, Miami, FL 33131
  • Phone: 510-906-4600
  1. Stock Information:
  • Common Stock: The company has common stock with a par value of $0.001 per share.
  • Ticker Symbol: PLSE
  • Exchange: NASDAQ
  1. Reporting Context:
  • The context ID for the report is "d20258K", which may reference a specific reporting period or event.
  1. Period:
  • The reporting period starts and ends on the same date, January 9, 2025, indicating that this filing pertains to a specific event or announcement occurring on that date.

Insights:

  • The 8-K filing indicates that Pulse Biosciences, Inc. may have significant news or events to disclose, which could have an impact on its stock performance or investor relations.
  • The company is listed on NASDAQ, which suggests it has met the regulatory requirements for public companies.
  • The filing date and the reporting period being the same suggests it may relate to an immediate or urgent matter that required timely disclosure to shareholders and the market.

This summary provides a concise overview of key financial report elements for Pulse Biosciences, Inc. as of January 9, 2025.